Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy

Muscle and Nerve

Volumn 33, Issue 2, 2006, Pages 225-231

  Shu, Xiao Mei ^a   Cai, Fang Cheng ^a   Zhang, Xiao Ping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Campylobacter jejuni; galE gene; Ganglioside; Guillain Barr syndrome; Lipooligosaccharide; Mimicry; Pathology; Peripheral nerve

Indexed keywords

CARBOHYDRATE; EPITOPE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; LIPOOLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; DEMYELINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GALE GENE; GENE EXPRESSION; GUILLAIN BARRE SYNDROME; GUINEA PIG; IMMUNIZATION; INOCULATION; MOLECULAR MIMICRY; MORPHOLOGY; MUTANT; NERVE FIBER DEGENERATION; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE;

ANIMALS; AUTOANTIBODIES; BACTERIAL PROTEINS; BLOTTING, WESTERN; CAMPYLOBACTER JEJUNI; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; FEMALE; G(M1) GANGLIOSIDE; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUILLAIN-BARRE SYNDROME; GUINEA PIGS; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MOLECULAR MIMICRY; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; SCIATIC NERVE; UDPGLUCOSE 4-EPIMERASE;

EID: 32144442704     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20457     Document Type: Article

References (20)

1. Ang CW, De Klerk MA, Endtz HP, Jacobs BC, Laman JD, van der Meché FGA, et al. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits. Infect Immun 2001;69:2462-2469.
2. Aspinall GO, Fujimoto S, McDonald AG, Pang H, Kurjanczyk LA, Penner JL. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun 1994;2:2122-2125.
3. Aspinall GO, McDonald AG, Pang H, Kurjanczyk LA, Penner JL. Lipopolysaccharides of Campylobacter jejuni serotype O:19:structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 1994;3:241-249.
4. Chowdhury D, Arora A. Axonal Guillain-Barré syndrome: a critical review. Acta Neurol Scand 2001;103:267-277.
5. Dyck PJ. Pathological alterations of the peripheral nerves. In: Dyck PJ, Thomas PK, Lambert E, editors. Peripheral neuropathy, 3rd ed. Philadelphia: Saunders; 1993. p 536-542.
6. Fry BN, Feng S, Chen YY, Newell DG, Coloe PJ, Korolik V. The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. Infect Immun 2000;68:2594-2601.
7. Godschalk PCR, Heikema AP, Gilbert M, Komagamine T, Ang CW, Glerum J, et al. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome. J Clin Invest 2004;114:1659-1665.
8. Guerry P, Ewing CP, Hickey TE, Prendergast MM., Moran AP. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect Immun 2000;68:6656-6662.
9. Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, Pattarini DL, et al. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun 2002;70:787-793.
10. Hughes RAC, Hadden RDM, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol 1999;100:74-97.
11. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 1996;39:424-431.
12. Linton D, Karlyshev AV, Hitchen PG, Morris HR, Dell A, Gregson NA, et al. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipooligosaccharide. Mol Microbiol 2000;35:1120-1134.
13. Mizisin AP, Wiley CA, Hughes RAC, Powell HC. Peripheral nerve demyelination in rabbits after inoculation with Freund's complete adjuvant alone or in combination with lipid haptens. J Neuroimmunol 1987;16:381-395.
14. Moran AP. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. J Infect Dis 1997;176(suppl 2):S115-S121.
15. Penner JL, Aspinall GO. Diversity of lipopolysaccharide structures in Campylobacter jejuni. J Infect Dis 1997;176(suppl 2):S135-S138.
16. Saida T, Saida K, Dorfman SH, Silberberg DH, Sumner AJ, Manning MC, et al. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 1979;204:103-1106.
17. Skirrow MB. Campylobacter enteritis: a "new" disease. BMJ 1977;2:9-11.
18. Thomas FP, Trojaborg W, Nagy C, Santoro M, Sadiq SA, Latov N, et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol 1991;82:378-383.
19. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125:2591-2625.
20. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci USA 2004;101:11404-11409.